Avalyn Pharma Inc.

Contributing Author

Recent Articles by Avalyn Pharma Inc.

May-27	Avalyn to Participate in the Jefferies Global Healthcare Conference AVLN GlobeNewswire
May-21	Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026 AVLN GlobeNewswire
May-05	Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference AVLN -5.64% GlobeNewswire
May-01	Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares AVLN GlobeNewswire